夏维波，1967年生，籍贯宁夏盐池，内分泌学家，北京协和医院主任医师，博士生导师。1983年考入宁夏医学院医疗专业，1988年获得学士学位。1992年在大连医科大学内科学专业攻读硕士学位，从事高血压研究。1995年在中国协和医科大学内分泌专业攻读博士学位，从事骨代谢疾病研究。1998年开始在北京协和医院内分泌科工作，主要从事内分泌和代谢性疾病的临床和研究工作。 2003年升为副主任医师，2008年晋升为主任医师。

主要从事内分泌和代谢疾病的临床和研究工作，对遗传性内分泌代谢疾病具有丰富的诊疗经验。专注于骨质疏松症的流行病学和防治，维生素D代谢、佝偻病、骨软化症和甲状旁腺疾病的发病机制和诊治。

全国十大赌博官网

1. Ni X#, Feng Y, Guan W, Chi Y, Li X, Gong Y, Zhao N, Pang Q, Yu W, Wu H, Huo L, Liu Y, Jin J, Zhou X, Lv W, Zhou L, Xia Y, Liu W, Jiajue R, Wang O, Li M, Xing X, Fukumoto S, Jiang Y, Xia W*. Bone Impairment in a Large Cohort of Chinese Patients With Tumor-Induced Osteomalacia Assessed by HR-pQCT and TBS. J Bone Miner Res. 2022; 37(3):454-464. (IF=6.390)

2. Gong Y#, Ni X#, Jin C, Li X, Wang Y, Wang O, Li M, Xing X, Wu Z, Jiang Y, Xia W*. Serum Metabolomics Reveals Dysregulation and Diagnostic Potential of Oxylipins in Tumor-induced Osteomalacia. J Clin Endocrinol Metab. 2022; 107(5):1383-1391. (IF=6.134)

3. Li Q#, Zhao Z, Wu B, Pang Q, Cui L, Zhang L, Jiang Y, Wang O, Li M, Xing X, Hu Y, Yu W, Meng X, Jiajue R, Xia W*. Alteration of Bone Density, Microarchitecture, and Strength in Patients with Camurati-Engelmann Disease: Assessed by HR-pQCT. J Bone Miner Res. 2022;37(1):78-86. (IF=6.390)

4. Wang L#, Yu W#, Yin X#, Cui L#, Tang S, Jiang N, Cui L, Zhao N, Lin Q, Chen L, Lin H, Jin X, Dong Z, Ren Z, Hou Z, Zhang Y, Zhong J, Cai S, Liu Y, Meng R, Deng Y, Ding X, Ma J, Xie Z, Shen L, Wu W, Zhang M, Ying Q, Zeng Y, Dong J, Cummings SR, Li Z, Xia W*. Prevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence Study. JAMA Netw Open. 2021; 4(8):e2121106. (IF=13.353)

5. Jiajue R#, Ni X, Jin C, Huo L, Wu H, Liu Y, Jin J, Yu W, Lv W, Zhou L, Xia Y, Chi Y, Cui L, Pang Q, Li X, Jiang Y, Wang O, Li M, Xing X, Meng X, Xia W*. Early Discrimination Between Tumor-Induced Rickets/Osteomalacia and X-Linked Hypophosphatemia in Chinese Children and Adolescents: A Retrospective Case-Control Study. J Bone Miner Res. 2021; 36(9):1739-1748. (IF=6.390)

6. Jiang Y#, Li X#, Huo L, Liu Y, Lyu W, Zhou L, Yu W, Wu HW, Xing XP, Li M, Wang O, Chi Y, Jiajue RZ, Pei Y, Liu JM, Ba JM, Zhang Q, Sheng ZF, Zhang ZL, Zhao JJ*, Minisola S*, Xia WB*; Chinese Society of Osteoporosis and Bone Mineral Research and Chinese Society of Endocrinology. Consensus on clinical management of tumor-induced osteomalacia. Chin Med J (Engl). 2021;134(11):1264-1266. (IF=6.133)

7. Li X#, Jiang Y, Huo L, Wu H, Liu Y, Jin J, Yu W, Lv W, Zhou L, Xia Y, Wang O, Li M, Xing X, Chi Y, Jiajue R, Cui L, Meng X, Xia W*. Nonremission and Recurrent Tumor-Induced Osteomalacia: A Retrospective Study. J Bone Miner Res. 2020;35(3):469-477. (IF=6.390)

8. Zhang C#, Zhao Z, Sun Y, Xu L, JiaJue R, Cui L, Pang Q, Jiang Y, Li M, Wang O, He X, He S, Nie M, Xing X, Meng X, Zhou X, Yan L, Kaplan JM, Insogna KL, Xia W*. Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia. Bone. 2019 ;121:212-220. (IF=4.626)

9. Wu B,# Wang O, Jiang Y, Li M, Xing X, Xia W*. Atypical skeletal manifestations of rickets in a familial hypocalciuric hypercalcemia patient. Bone Res. 2017;27;5:17001. D. (IF=9.326)

10. Xia WB#, He SL, Xu L*, Liu AM, Jiang Y, Li M, Wang O, Xing XP, Sun Y, Cummings SR. Rapidly increasing rates of hip fracture in Beijing, China. J Bone Miner Res. 2012 Jan;27(1):125-9. (IF=6.373)